Insider Selling: Dr. Martens (LON:DOCS) Insider Sells 298,675 Shares of Stock

Key Points

• Insider Ije Nwokori sold 298,675 shares of Dr. Martens stock on October 15th, totaling £268,807.50 at an average price of GBX 90 per share.
• Dr. Martens has an average rating of "Hold" from analysts, with one "Buy" rating and two "Hold" ratings, reflecting a cautious outlook on the stock.
• The company's stock price has experienced a 52-week range between GBX 43.02 and GBX 100.87, indicating significant volatility in its market performance.

Dr. Martens plc (LON:DOCS - Get Free Report) insider Ije Nwokori sold 298,675 shares of the firm's stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of GBX 90, for a total transaction of £268,807.50.

Ije Nwokori also recently made the following trade(s):

• On Monday, October 13th, Ije Nwokori bought 167 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 89 per share, for a total transaction of £148.63.
• On Wednesday, October 8th, Ije Nwokori acquired 136 shares of Dr. Martens stock. The stock was purchased at an average price of GBX 90 per share, with a total value of £122.40.
• On Monday, August 11th, Ije Nwokori bought 194 shares of Dr. Martens stock. The stock was purchased at an average cost of GBX 77 per share, for a total transaction of £149.38.

Dr. Martens Price Performance

Shares of DOCS traded down GBX 1.05 during trading hours on Friday, hitting GBX 90. The stock had a trading volume of 489,390 shares, compared to its average volume of 2,234,775. Dr. Martens plc has a 52 week low of GBX 43.02 and a 52 week high of GBX 100.87. The company's fifty day moving average is GBX 89.22 and its two-hundred day moving average is GBX 73.77. The company has a debt-to-equity ratio of 127.27, a current ratio of 2.85 and a quick ratio of 1.13. The stock has a market capitalization of £869.10 million, a price-to-earnings ratio of 18,000.00, a P/E/G ratio of 6.40 and a beta of 0.11.

Wall Street Analyst Weigh In

DOCS has been the subject of several analyst reports. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Dr. Martens in a research note on Friday, July 11th. Peel Hunt raised shares of Dr. Martens to a "buy" rating in a research note on Monday, August 18th. One investment analyst has rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of GBX 6,000.

About Dr. Martens

Founded in 1960, Dr. Martens is an iconic British brand with a global presence. “Docs” or “DMs” were originally produced for their durability for workers, before being adopted by diverse youth subcultures and associated musical movements. Today, Dr. Martens has transcended its roots while still celebrating its proud history.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.